Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications - Wikidata - awgldk - TriplyDB

Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications

Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications

http://www.wikidata.org/entity/Q34796662

about

Biosafe nanoscale pharmaceutical adjuvant materials Delivery of host cell-directed therapeutics for intracellular pathogen clearance Persistence, distribution, and impact of distinctly segmented microparticles on cochlear health following in vivo infusion.Facile Preparation of Nanogels Using Activated Ester Containing Polymers.Carbohydrate polymers for nonviral nucleic acid delivery.In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection.Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy.Development of a Vinyl Ether-Functionalized Polyphosphoester as a Template for Multiple Postpolymerization Conjugation Chemistries and Study of Core Degradable Polymeric Nanoparticles Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics.Synthesis of polysaccharide-block-polypeptide copolymer for potential co-delivery of drug and plasmid DNA.Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.Engineering dextran-based scaffolds for drug delivery and tissue repair.Modified dextran, heparin-based triggered release microspheres for cardiovascular delivery of therapeutic drugs using protamine as a stimulus.Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.Aerosolized antimicrobial agents based on degradable dextran nanoparticles loaded with silver carbene complexes.Reactive Self-Assembly of Polymers and Proteins to Reversibly Silence a Killer Protein.Poly(ortho ester amides): acid-labile temperature-responsive copolymers for potential biomedical applications In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis.Chemoselective ligation in the functionalization of polysaccharide-based particles.Microscopy and tunable resistive pulse sensing characterization of the swelling of pH-responsive, polymeric expansile nanoparticles.Biodegradable 'intelligent' materials in response to chemical stimuli for biomedical applications.Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI.A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals.Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticles Tailoring nanocarriers for intracellular protein delivery.Recent advances in stimuli-responsive degradable block copolymer micelles: synthesis and controlled drug delivery applications.Biologically responsive polymeric nanoparticles for drug delivery.Acid-degradable polymers for drug delivery: a decade of innovation.Smart chemistry in polymeric nanomedicine.Photo-responsive polymeric micelles.Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles.Programmable nanomedicine: synergistic and sequential drug delivery systems.Interfacing materials science and biology for drug carrier design.Chloroquine-Modified Hydroxyethyl Starch as a Polymeric Drug for Cancer Therapy.Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.

P2860

Q26829798-5EF8F7E5-3AE7-4902-A53F-72F5FFBC65F6 Q27006858-0446D2BD-A938-4D5E-BBB2-9F450A0F0067 Q30828850-5F7460B1-B714-43E6-B4E7-DE20AAF914BE Q30884118-F9ECC27E-7A08-4426-9115-18CC36AF14C4 Q33897565-B42BA0F2-0739-4E49-A2D5-5D5BBD92C109 Q33901007-66777FE3-F101-407C-AD66-7BFE1B06739F Q34450753-C35B22C5-2FF0-4BDE-9673-6679DED41BFD Q34564854-A7E35CF3-40B6-4C00-A769-782A9DE31DE4 Q34968934-21DBB438-6DDB-4D74-8706-2848EBB6FAB7 Q34975319-ADAD21C4-CD9B-4F80-96D1-74171C3A0E4E Q35155064-BEF57060-638D-44DB-8E7B-730259D42604 Q35575232-505DB8C8-BD52-4035-8B59-1107C7AD8EC9 Q36047076-3FA9F592-56EA-475B-B123-66FA7DDF3429 Q36122915-92555943-E32D-4168-BFF4-3728C0C376E2 Q36205757-1AA65FAC-B888-45CF-9EA3-6E7B1D89BB74 Q36354901-8FB34B8C-CB4D-442B-B390-A2733E74C789 Q36372323-02A1A8F3-1380-4AE4-8DBF-C330CD914877 Q36630649-D99E36BD-562B-48B9-BBB7-415EF8936F23 Q36816995-02F67DD5-CEB4-49D1-A0DC-D083FA972AD1 Q37196562-E2085E10-B22D-45E6-B122-894FCFE6BA09 Q37317946-83A5491C-5614-4071-B233-E7BBA77001A4 Q37378031-4A7D14CF-0B13-4DA9-AE98-ED87DAF71330 Q37381177-3A973C10-2935-49F0-A4BC-DE4D15D5BC9D Q37427209-87C520FC-9CF4-4D19-BF81-2A36F69B6393 Q37481372-6592B61B-566F-4929-838B-13825588A345 Q37542987-6E9995E7-B0E1-43E1-A4FB-EBFE3B462A90 Q37625279-07799AC6-5D54-45AF-81AF-89C38C7DCEC9 Q37641455-858663A2-E199-4A03-B44C-27351A52CAAD Q37714122-BF68A3AC-F668-438D-838C-ECB0EAF8D7DF Q37874945-B5453C00-76F4-4CEE-A397-96B2723F15B5 Q38022037-625052FA-09F8-4CAB-90A8-915CE19CB7C6 Q38044396-C28EF066-D6F9-4521-9CDF-3AAAD7654BA5 Q38074172-A52709E0-6BB3-4E1E-B3A9-FFB0A8C5BE84 Q38221776-BE4282D3-FB7F-4918-9BD2-A34CB245DDD0 Q38232193-E4829CFD-FB01-43EF-B3F3-E1781EDDB611 Q38248809-971B52D6-A1F6-4CD0-B200-317AF8E92221 Q38336134-67C2E38C-65BF-4008-9394-3AE8A9BE253C Q38366527-66C24BA8-27AE-4465-A44D-45387126C2DA Q38657644-78FD6720-AAF1-4117-99E3-D4985F5FC321 Q38749645-A3D98082-8979-4B92-AD8E-99562DBBE8C8

P2860

Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications

http://www.wikidata.org/entity/Q34796662

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Acetal-derivatized dextran: an ...... l for therapeutic applications

@ast

Acetal-derivatized dextran: an ...... l for therapeutic applications

@en

Acetal-derivatized dextran: an ...... l for therapeutic applications

@nl

type

label

Acetal-derivatized dextran: an ...... l for therapeutic applications

@ast

Acetal-derivatized dextran: an ...... l for therapeutic applications

@en

Acetal-derivatized dextran: an ...... l for therapeutic applications

@nl

prefLabel

Acetal-derivatized dextran: an ...... l for therapeutic applications

@ast

Acetal-derivatized dextran: an ...... l for therapeutic applications

@en

Acetal-derivatized dextran: an ...... l for therapeutic applications

@nl

P1433

Q34796662-0069B14F-38CF-4079-BB2F-1B99FDA1E072

P1476

Q34796662-A80C35AF-699A-45B1-A04F-2D60E0C5376A

P2093

Q34796662-19EA3880-7CDA-4A4C-90E9-0E2E2E78BE94

Q34796662-9C91185E-1C89-44C6-AB13-FA98C5E0F1F4

Q34796662-B1B52148-0E42-4874-B5ED-28589FEAC675

P2860

Q34796662-023A4E83-43BF-4DC9-A437-B4CF95EF18EF

Q34796662-0D3729B8-8F38-43AC-BACB-CF152BC6647C

Q34796662-23C46A1F-693A-492C-B52B-BAEB12F9920D

Q34796662-2E08A8FF-F394-4A7A-AF01-94B8F3DE79B9

Q34796662-31620A8F-9F44-487F-87AE-72EF23D93C32

Q34796662-4BF69FE2-5216-4B4E-A25B-08AC042D7AB7

Q34796662-5DC3EA8C-2300-4D59-9988-5640ECF732CB

Q34796662-5E94AED6-E78F-4FB7-AB2F-1D12EA867F78

Q34796662-743E9578-B61C-4B31-B88E-5F330031B91A

Q34796662-75762A2C-DA75-4915-BC45-2A8935C278FC

P304

Q34796662-5B54B716-B3D7-489C-B52A-730612844D94

P31

Q34796662-694090AD-AF0D-42F2-B4B4-281B30736729

P356

Q34796662-B5071327-BFF6-4270-B248-4B5EDA5C2140

P407

Q34796662-E0144CCB-589C-4AE3-BD6A-A7791047FA74

P433

Q34796662-906C4294-C66C-463C-B8E6-DC553DFB0B97

P478

Q34796662-1F58BB54-E15A-40B9-A737-431AD9C98E44

P50

Q34796662-0A58B7F6-5D5E-4037-B274-7D23C07404C6

Q34796662-E53F4608-8DC9-4772-B25D-CFB15B28F8DC

P577

Q34796662-3E1F5E81-2BEE-4208-9F6C-F731AF9E9399

P5875

Q34796662-129224B9-154B-4435-8F90-57EF807F44A6

P698

Q34796662-CF236D90-6BE4-498E-8FD4-D7CAE52C764B

P921

Q34796662-04D83244-F1B1-4E8D-9BAB-8292C35F8EFD

P932

Q34796662-402592F4-6E36-4A19-8AB9-8CAC93016541

P356

P1433

Journal of the American Chemical Society

P1476

Acetal-derivatized dextran: an ...... l for therapeutic applications

@en

P2093

Eric M Bachelder

http://www.w3.org/2001/XMLSchema#string

Jesse Dashe

http://www.w3.org/2001/XMLSchema#string

Tristan T Beaudette

http://www.w3.org/2001/XMLSchema#string

P2860

Acetals as pH-sensitive linkages for drug delivery

A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels

Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms, with special emphasis on vacuolar-type proton ATPase.

Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines.

Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene.

Timed-release depot for anticancer agents.

Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.

Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery.

Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.

"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

P304

10494-10495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA803947S

http://www.w3.org/2001/XMLSchema#string

P407

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Kyle E. Broaders

P577

2008-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51405642

http://www.w3.org/2001/XMLSchema#string

P698

18630909

http://www.w3.org/2001/XMLSchema#string

P921

P932

2673804

http://www.w3.org/2001/XMLSchema#string